跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,733 条关于
“EGFR degrader”
全部
3,733
临床试验
2,016
药物
459
机构
3
资讯
1,255
4个月前
AstraZeneca Exercises Option for Pinetree's First-in-Class EGFR Degrader in $500M+ Deal
11个月前
Pinetree Therapeutics Secures $47 Million Series B to Advance Novel Protein Degraders for Drug-Resistant Cancers
去年
C4 Therapeutics Announces 2025 Milestones for Oncology-Focused Degrader Medicines
去年
Ramucirumab Plus Osimertinib Extends PFS in EGFR-Mutated NSCLC
去年
ctDNA Clearance Predicts Improved Outcomes in EGFR-Mutated NSCLC Treated with Icotinib
上个月
Dong-A ST Posts Record Q2 Sales of KRW 207.8 Billion, Operating Profit Surges 170%
2年前
Prelude Therapeutics' PRT3789 Shows Promise in SMARCA4-Mutated Cancers
11个月前
Foghorn Therapeutics Reports Breakthrough Progress in Selective ARID1B Degrader for Cancer Treatment
去年
Nurix Therapeutics Advances Bexobrutideg Phase III Program and Expands Protein Degrader Pipeline
去年
BlossomHill Therapeutics Advances EGFR-Mutant NSCLC Treatment with First-in-Class OMNI-EGFR Inhibitor BH-30643
第 1 页,共 126 页
上一页
下一页